PMID: 9661018Jul 14, 1998Paper

Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)

Antimicrobial Agents and Chemotherapy
M A PfallerK Kugler

Abstract

The SENTRY Program was established in January 1997 to measure the predominant pathogens and antimicrobial resistance patterns of nosocomial and community-acquired infections over a broad network of sentinel hospitals in the United States (30 sites), Canada (8 sites), South America (10 sites), and Europe (24 sites). During the first 6-month study period (January to June 1997), a total of 5,058 bloodstream infections (BSI) were reported by North American SENTRY participants (4,119 from the United States and 939 from Canada). In both the United States and Canada, Staphylococcus aureus and Escherichia coli were the most common BSI isolates, followed by coagulase-negative staphylococci and enterococci. Klebsiella spp., Enterobacter spp., Pseudomonas aeruginosa, Streptococcus pneumoniae, and beta-hemolytic streptococci were also among the 10 most frequently reported species in both the United States and Canada. Although the rank orders of pathogens in the United States and Canada were similar, distinct differences were noted in the antimicrobial susceptibilities of several pathogens. Overall, U.S. isolates were considerably more resistant than those from Canada. The differences in the proportions of oxacillin-resistant S. aureus isol...Continue Reading

References

Apr 1, 1992·The Journal of Antimicrobial Chemotherapy·W R Jarvis, W J Martone
Feb 1, 1991·American Journal of Infection Control·T G EmoriR P Gaynes
Oct 1, 1993·Clinical Microbiology Reviews·T G Emori, R P Gaynes
Feb 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L ArchibaldR Gaynes
Apr 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M P WeinsteinL B Reller
Jun 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D PittetR P Wenzel
Jul 1, 1997·Clinical Microbiology Reviews·L G ReimerM P Weinstein

❮ Previous
Next ❯

Citations

May 11, 2001·The Annals of Pharmacotherapy·K T Bain, E T Wittbrodt
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F C Tenover
Jan 31, 2002·American Journal of Clinical Dermatology·Joseph M Blondeau
May 25, 2002·Emerging Infectious Diseases·John QualeSimona Bratu
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·Van CaoPatrice Courvalin
Aug 19, 2003·Pharmacotherapy·Michael D KraftBruce A Mueller
Jan 7, 2004·Nature Reviews. Genetics·Claire M Fraser
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Laurel S AlmerVirginia D Shortridge
Oct 16, 2004·Expert Review of Anti-infective Therapy·Ian Chopra
Feb 8, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Todd D BartonEbbing Lautenbach
Feb 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James A KarlowskyDaniel F Sahm
Sep 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ebbing LautenbachNeil O Fishman
Oct 6, 2005·Surgical Infections·Jose M Tellado, Samuel E Wilson
Oct 3, 2006·Biochemistry. Biokhimii︠a︡·Yu S Ovodov
Jan 24, 2009·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Jiro Fujita
Oct 6, 2009·Revista Da Sociedade Brasileira De Medicina Tropical·Diana Christina Pereira Santos GonçalvesJosé Daniel Gonçalves Vieira
Jun 12, 2013·Expert Opinion on Pharmacotherapy·Panagiotis Poulikakos, Matthew E Falagas
Nov 6, 2013·Expert Review of Anti-infective Therapy·Mette SøgaardHenrik Carl Schønheyder
Mar 16, 2000·Drugs·D I Diekema, R N Jones
Nov 30, 2000·Current Infectious Disease Reports·L R Baden, B I Eisenstein
Apr 17, 2001·The Pediatric Infectious Disease Journal·R E Kessler
Nov 30, 2000·Current Infectious Disease Reports·P Linden
Apr 17, 2001·Antimicrobial Agents and Chemotherapy·S ChamberlandM N Dudley
Aug 31, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Ebbing LautenbachNeil O Fishman
Jun 28, 2005·Antimicrobial Agents and Chemotherapy·P Margreet G FiliusHubert P Endtz
Jul 12, 2005·Chemotherapy·Herman Goossens

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

© 2022 Meta ULC. All rights reserved